J&J CFO on acetaminophen: ‘There’s no basis to believe it’s dangerous’

Joe Wolk, Johnson & Johnson CFO, joins Yahoo Finance’s Adam Shapiro and Julie Hyman to discuss its fourth-quarter earnings report, talc baby powder, the current controversy around Acetaminophen and why the Johnson & Johnson board will not split its portfolio. …read more

Source:: Yahoo Finance

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.